Adocia Initiates Phase 2 Clinical Trial
Adocia Initiates Phase 2 Clinical Trial for M1Pram in Patients with Type 1 Diabetes
- Phase 2 study evaluates safety and efficacy of M1Pram, assessing weight loss in overweight and obese T1D patients as well as improved HbA1c
- The study has been designed to define parameters for the upcoming Phase 3 trial planned for 2022
- This study follows the promising results of the proof-of-concept Phase 1 trial announced on September 15, 2020
Read the press release
Diary - News
All news Adocia Initiates Phase 2 Clinical Trial 